4 completed, 1 terminated. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Terminated 1 |
Follow EmitBio Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting RDX-19 - Post COVID-19 Condition (PCC) | Not applicable | Terminated | EmitBio Inc. | 41 | 2023-10-30 | 2024-07-05 |
| Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19 RD-X19, Sham - COVID-19 | Not applicable | Completed | EmitBio Inc. | 330 | 2023-04-21 | 2024-10-24 |
| Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19 RD-X19, Sham - COVID19 | Not applicable | Completed | EmitBio Inc. | 216 | 2021-06-17 | 2024-09-19 |
| Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19 RD-X19 - COVID19 | Not applicable | Completed | EmitBio Inc. | 31 | 2020-11-18 | 2022-09-08 |
| Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens RD19 - Respiratory Tract Infections | Not applicable | Completed | EmitBio Inc. | 25 | 2020-08-31 | 2024-10-03 |
COVID-19 (3) · Respiratory Tract Infections (1)
United States (5)
Lisa M Cohen, DO (1)